R&D
🇺🇸 FDA Page 4FDA news and analysis for pharmaceutical BD, investment, and market access · 12 articles on this page
Gain critical insights into global pharmaceutical R&D trends, drug discovery pipelines, and clinical trial advancements. Drive your pharma strategy.
Showing 37–48 of 117 articles
Johnson And Johnson ASCO 2026 Data Adds Depth To JNJ Valuation Story
Pfizer's Berobenatide Obesity Drug: VESPER-3 Data and Competitive Outlook
Puma Biotechnology Inducement Awards: Strategic Talent Moves Under Nasdaq Rule 5635(c)(4)
Eli Lilly Retatrutide Phase 3: Safety Data and Competitive Implications
Pfizer's Berobenatide: Monthly Obesity Drug Shows Promise in Phase 2b
Lundbeck Advances Lu AG09222 After Phase 2 Migraine Data
Revolution Medicines' Daraxonrasib: Pancreatic Cancer Breakthrough and Beyond
Celcuity Expands VIKTORIA-2 Trial as Shares Trade Below Analyst Targets
FDA Flavored Vape Ban: Youth Risk and Pharma Implications
Opinion: I led the CDC response to the 2014 Ebola epidemic. The new outbreak needs massive
Amish Health Beliefs: Vaccines, Costs, and Pharma Strategy Insights
STAT+: What stripping civil service protections for thousands of federal workers will mean for HHS